Even if saliva is a dead-end we need to get to market -- then look to get the multiplex Covid/Flu test to market too. The multiplex is still a differentiator.
Ann: Therapeutic Goods Administration Registration Submitted, page-34
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.5¢ |
Change
0.003(13.6%) |
Mkt cap ! $61.60M | |||
| Open | High | Low | Value | Volume |
| 2.3¢ | 2.7¢ | 2.3¢ | $469.2K | 19.13M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 4440748 | 2.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 1105729 | 6 |
View Market Depth
| Last trade - 15.27pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.5¢ |
Change
0.003 ( 19.1 %) |
||||
| Open | High | Low | Volume | ||
| 2.4¢ | 2.7¢ | 2.4¢ | 14811192 | ||
| Last updated 15.48pm 22/05/2024 ? | |||||
| ADO (ASX) Chart |